Menü
sharewise zieht um Am Wochenende vom 22./23. August wird das neue sharewise die Hauptseite. Schau es dir jetzt an und sag uns, was dir fehlt. Zum neuen sharewise Was sich ändert
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Here's How Capital Discipline Powers Berkshire's Long-Term Growth


The success of Warren Buffett’s leadership at Berkshire Hathaway BRK.B stems largely from its disciplined capital allocation—deploying funds only when risk-adjusted returns justify the investment. This approach has allowed the company to steadily compound shareholder wealth while limiting the risk of permanent capital loss. Unlike many conglomerates that chase expansion, Berkshire invests selectively, committing capital only when opportunities trade meaningfully below intrinsic value. 

In 2025, this discipline was reflected in Berkshire’s acquisition of two distinct businesses: OxyChem and Bell Laboratories. Berkshire came across OxyChem through its investment in Occidental. OxyChem produces chlorine and caustic soda for essential end markets such as construction and core industries. Its focus on operational efficiency, integrated assets and low-cost raw materials supports stable cash generation. Bell Laboratories offers high margins, strong historical and future growth potential, and capable management. Together, these businesses strengthen Berkshire’s operating portfolio—some generating excess cash with minimal reinvestment needs, while others provide opportunities for long-term compounding.

Its large cash and U.S. Treasury holdings (exceeding $370 billion at 2025 end) and a solid float ($176 billion at the end of 2025) support its prudent capital allocation.

Berkshire repurchases shares only when they trade below intrinsic value, a disciplined approach that enhances shareholder value by increasing ownership stakes in its portfolio of high-quality businesses.

Over time, Berkshire’s patient and opportunistic capital allocation supports compounding by preserving financial strength, avoiding misallocation, and investing significantly only when valuations are attractive, enabling sustained long-term shareholder returns.

What About BRK.B’s Peers?

Progressive Corporation PGR demonstrates strong capital discipline by aligning underwriting profitability with prudent capital deployment. Progressive reinvests capital into technological advancements, pricing analytics and selective market expansion. This disciplined approach enables Progressive Corp. to sustain growth while protecting underwriting margins.

Like Progressive, Allstate Corporation ALL exercises capital discipline through capital deployment while investing in digital capabilities and product expansion. Allstate’s capital deployment includes share buybacks and dividend payouts. This balanced strategy allows Allstate to strengthen profitability while supporting long-term growth.

BRK.B’s Price Performance

Shares of BRK.B have lost 1.7% year to date, outperforming the industry.

Zacks Investment Research
Image Source: Zacks Investment Research

BRK.B’s Expensive Valuation

BRK.B trades at a price-to-book value ratio of 1.47, above the industry average of 1.38. It carries a Value Score of D.

Zacks Investment Research
Image Source: Zacks Investment Research

Estimate Movement for BRK.B

The Zacks Consensus Estimate for BRK.B’s first-quarter 2026 EPS moved 0.8% north over the last 30 days, whereas that for second-quarter 2026 remained unchanged over the same period. The same for 2026 and 2027 EPS estimates moved 0.8% south each in the last 30 days.

Zacks Investment Research
Image Source: Zacks Investment Research

The consensus estimates for BRK.B’s 2026 and 2027 revenues and EPS indicate year-over-year increases.  

BRK.B stock currently carries a Zacks Rank #4 (Sell). 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Zacks' Research Chief Picks Stock Most Likely to "At Least Double"

Our experts have revealed their Top 5 recommendations with money-doubling potential – and Director of Research Sheraz Mian believes one is superior to the others. Of course, all our picks aren’t winners but this one could far surpass earlier recommendations like Hims & Hers Health, which shot up +209%.

See Our Top Stock to Double (Plus 4 Runners Up) >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Berkshire Hathaway Inc. (BRK.B): Free Stock Analysis Report
 
The Allstate Corporation (ALL): Free Stock Analysis Report
 
The Progressive Corporation (PGR): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research


Source Zacks-com

Like: 0
Teilen
At Zacks, we are dedicated to independent investment research, helping investors succeed through tools like our Zacks Rank stock-rating system, which has averaged +23.89% annual returns since 1988. Founded on the discovery that earnings estimate revisions drive stock prices, we offer purely mathematical, unbiased ratings, along with additional innovations like the Price Response Indicator, Earnings ESP, and specialized rankings for mutual funds and ETFs.
...
Rechtlicher Hinweis

Kommentare